The story of Sildenafil offers a complicated case study for analysts eyeing drug companies. While initial sales were astounding, present patent expiry and the rise of generic versions have considerably influenced earnings. Furthermore, increasing regulatory oversight and calls to decrease prescription prices pose continuous challenges. Thus, bet… Read More

The emergence of so-called "Elite Gambler's The Pill" – often referring to exceptionally high doses ordered by rogue physicians – represents a particularly alarming trend. While typical dosages of Sildenafil are intended for treating erectile dysfunction safely in most individuals, these significantly elevated amounts pose a grave threat to car… Read More